Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasmodium Falciparum Molecular Surveillance in Mozambique to Monitor Markers of Antimalarial Drug Resistance, Rapid Tests Diagnostic Failure and Transmission in Mozambique: Phase 2

NCT06529237 is registered in ClinicalTrials.gov with Centro de Investigacao em Saude de Manhica as lead sponsor.

NCT NCT06529237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06529237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasmodium Falciparum Molecular Surveillance in Mozambique to Monitor Markers of Antimalarial Drug Resistance, Rapid Tests Diagnostic Failure and Transmission in Mozambique: Phase 2
Lead sponsor
Centro de Investigacao em Saude de Manhica
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2024
Completion date
March 31, 2027
Enrollment
18,750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

falciparum malaria, malaria, malaria in pregnancy